* Elutia Inc ELUT.OQ reported a quarterly adjusted loss
of 33
cents per share for the quarter , higher than the same quarter
last year, when the company reported EPS of -57 cents. The mean
expectation of two analysts for the quarter was for a loss of 44
cents per share. Wall Street expected results to range from -59
cents to -29 cents per share.
* Revenue fell 3.3% to $5.92 million from a year ago;
analysts
expected $6.60 million.
* Elutia Inc's reported EPS for the quarter was a loss of 33
cents.
* Elutia Inc shares had risen by 0.5% this quarter and
gained 77.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Elutia Inc is
10.00
This summary was machine generated from LSEG data November 15 at
02:03 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.44 -0.33 Beat
Jun. 30 2024 -0.33 -1.13 Missed
Mar. 31 2024 -0.41 -0.75 Missed
Dec. 31 2023 -0.28 -0.40 Missed